News

America is seeing huge growth in Synthetic Biology – the UK must ensure it doesn’t miss out.

bit.bio's Founder and CEO Mark Kotter talks to Kurier about reprogramming cells for therapies.

Read about the Babraham Investor Conference 2021 focusing on early-stage and scale-up life science and med-tech companies.

This piece focuses on the promise of stem cells for cell therapies.

Sci Foo Camp is run by Digital Science, Google, Nature Publishing Group and O’Reilly Media.

Cindy Yu talks to Mark Kotter about cultured meat and its possible impact on sustainability.

The piece covers potential treatments for dementia and muscular dystrophy with engineered human cells.

bit.bio CEO and founder Dr Mark Kotter was a speaker on the podcast Danny in the Valley.